Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Ampilio, a subsidiary of SpectrumOne, signs with Danish company CS MEDICA A/S to execute on expansion

Ampilio, a subsidiary of SpectrumOne, partners up with stock exchange listed medical company CS MEDICA as digital business strategist, growth specialists and executor of their  global expansion on Amazon. Ampilio will run all sales, digital strategy, and expansion on Amazon with a global launch. The deal is valued at 270 000 SEK annually with a continued agreement until either partner decides otherwise.  CS MEDICA is a Danish leading OTC Medical Device Provider active in medical technology. The company specializes in the development of medical devices. The portfolio includes products

BioStock: Abliva is ready for a pivotal year

During 2021 Lund-based Abliva laid the ground for an eventful 2022 as it achieved significant advancements with its two candidates within the primary mitochondrial disease space. Lead candidate KL1333 is to enter a registrational phase II/III study during 2022, whilst the second candidate, NV354, has been given the go-ahead to proceed to clinical studies. During the last days of 2021 the company also announced a directed issue of convertible bonds in order to further advance KL1333 and provide bridge financing.Read the article and interview with Abliva's CEO Ellen Donnelly at biostock.se (

Martin du Hane har utsetts till permanent VD och Koncernchef för Moment Group AB

Styrelsen har utsett Martin du Hane till permanent VD och Koncernchef för Moment Group AB. Martin du Hane tillträdde den 22 mars 2021 befattningen som tillförordnad VD/Koncernchef och den rollen har med detta övergått till att vara permanent.- Uppdraget för den som ytterst ska leda Moment Group framåt är tydligt – att återställa lönsamheten efter denna tuffa period med stängda verksamheter och samtidigt bygga plattformen för tillväxt. Vi har nu gjort ett grundligt arbete i rekryteringsprocessen för att finna rätt VD för koncernen och vi i styrelsen är mycket glada att Martin tackade ja till

Additional DrugLog order from B. Braun Spain

B. Braun Spain has placed another order for a complete DrugLog® system for installation at Hospital General Universitari de Castelló. The order is a result of the collaboration between B. Braun Spain and Pharmacolog.The collaboration between B. Braun Spain has been ongoing for a number of years where Pharmacolog's products DrugLog and PrepLog have been adapted to fit in with B. Braun's solutions for safe handling of critical drugs. The launch was delayed due to the pandemic but began in 2021. Today's order concerns installation at Hospital General Universitari de Castelló in Castello de la

HKScan plans to streamline its operating model

HKScan Corporation, Press Release, 3 February 2022, at 9:30 am EETHKScan plans to streamline its operating model  HKScan is planning to streamline the operating model between the Group functions and Business Units. In the future, HKScan’s Group functions are planned to focus more closely on the Group’s key strategic development projects and leadership as well as activities that ensure good corporate governance of a listed company. HKScan will begin statutory negotiations simultaneously in the Group functions and Business Unit Finland. HKScan renewed its Group-wide operating model at

SEB’s The Green Bond: Energy Investments to Surge in 2022

The cost advantage of renewable energy over fossil alternatives continues to widen, and incoming data is starting to confirm a surge in energy investment that will also accelerate the transition for energy-using sectors. SEB’s latest The Green Bond report explores this development, and how 2022 is likely to be the first year when total transition investment exceeds USD 1 trillion. In this issue of The Green Bond, titled Biodiversity in the Spotlight, we also take a deep dive into the topic of biodiversity – particularly looking at how businesses and investors are now moving beyond climate-

Year End Report 2021

Press release, Stockholm, Sweden, 3 February 2022 Good growth despite challenges Fourth quarter 2021 · Net sales increased during the fourth quarter by 23,2% to 83,5 MSEK (67,8). Currency translations had a positive effect of 1,4 MSEK on net sales. · Adjusted EBITDA decreased during the fourth quarter by 7,1% to 5,1 MSEK (5,5), corresponding to an adjusted EBITDA margin by 6,1 % (8,1) · Operating profit/loss was -1,7 MSEK (-1,0) which correspond to operating margin of -2,0% (-1,5) · Profit for the quarter was -4,3 MSEK (-2,6) · Result per share was -0,29 (-0,18) SEK[1]

Year-end report Rejlers AB January – December 2021

October – December   · Net sales increased by 32.4% to SEK 835.9 million (631.2) · Organic sales growth excluding exchange rate fluctuations increased to 22.1% (-5.1) · Adjusted EBITA, excluding restructuring costs, increased by 87% to SEK 66.5 million (35.6) and the adjusted EBITA margin increased to 8.0% (5.6). · Restructuring costs amounted to SEK 18.2 million (0) · EBITA increased to SEK 48.3 million (35.6) and the EBITA margin increased to 5.8% (5.6) · Operating profit (EBIT) increased to SEK 37.4 million (28.0), impacted by acquisition costs of SEK 2.5 million (2.7)

Hexagon Composites ASA: Invitation to presentation of fourth quarter 2021 results

Hexagon Composites ASA's fourth quarter results 2021 will be released on 17 February 2022, 07:00 CET. Jon Erik Engeset (CEO) and David Bandele (CFO) will present the results at 08:30 CET. The presentation will be held in the Auditorium at Hexagon's location in Oslo, Haakon VIIs gate 2, on the lower level. If you want to attend the presentation, you can pre-register by sending an email with your full name to ir@hexagongroup.com or register upon arrival. The presentation will also be broadcasted live via: https://channel.royalcast.com/landingpage/hegnarmedia/20220217_16/ A recording

Kesko's share-based commitment and incentive plans for 2022-2025

Kesko Corporation's Board of Directors has decided that the target group for the 2022–2023 performance period of Kesko’s share-based commitment and incentive plan PSP (Performance Share Plan) will comprise approximately 60 key members of Kesko’s management. The Board of Directors has also decided to establish a KPSP (Key Personnel Share Plan) share-based commitment and incentive plan, for other Kesko key persons selected separately. The target group for the KPSP for the 2022 performance period comprises approximately 160 persons. The Board has also confirmed the criteria for 2022 for the PSP

Proposals by the board of directors to the annual general meeting 2022

KONECRANES PLC STOCK EXCHANGE RELEASE February 3, 2022 at 09:15 am EET Proposals by the board of directors to the annual general meeting 2022 The Board of Directors of Konecranes Plc (“Konecranes” or the “Company”) has decided that the Annual General Meeting (the “AGM”) to be held on Wednesday 30 March 2022 at 10.00 am will be held with exceptional meeting procedures based on the temporary legislative act to limit the spread of the Covid-19 pandemic (375/2021). The Annual General Meeting will be held without shareholders’ and their proxy representatives’ presence at the meeting

Nightingale has completed the acquisition of Finnish genetic testing company Negen

Company release, 3 February 2022 at 9:15 a.m. (EET) Nightingale Health Plc (“Nightingale”) announced on 18 January 2022, that it has agreed on an acquisition where it purchases all shares of Finnish genetic testing company Negen Oy (“Negen”). The transaction was subject to certain conditions, which have been fulfilled and the transaction has been completed. Negen will be reported as part of Nightingale Health Group as of 3 February 2022. For further information, please contact: Teemu Suna, CEOir@nightingalehealth.com Certified Advisor: Oaklins Merasco Ltd, tel. +358 9 6129

Realisation of the 2020 and 2021 performance periods of Kesko's share-based commitment and incentive plan PSP 2020-2023

Kesko Corporation’s Board of Directors has decided, based on the fulfilment of the performance criteria for the 2020 and 2021 performance periods of the share-based commitment and incentive plan PSP 2020-2023, to grant a total of 653,622 Kesko B shares held by the company as treasury shares to the members of management and other key persons who were included in the target group. The Board has also decided, in accordance with the terms and conditions of the RSP 2019-2021 plan, to grant a total of 28,800 Kesko B shares to key persons in the company. The share numbers represent gross earnings,

Specsavers selects LINK Mobility to transform its conversational messaging

Oslo, Norway, 3 February 2022: Following a competitive procurement process, LINK Mobility (LINK), Europe’s leading provider of mobile messaging communications, today announces it has signed a long-term strategic partnership with Specsavers, a leader in optometry, audiology, and healthcare services. The partnership enables Specsavers to perform conversational messaging and marketing communications over SMS, Rich SMS and RCS.Under the terms of the agreement, LINK UK will provide the communication platforms that will transform the way Specsavers communicates and engages with its customers. The

Today is the last day of trading in Alzinova's warrants of series TO2 2020/2022

Today, 3 February 2022, is the last day of trading for the warrants of series TO2 2020/2022 (the “warrants”) which Alzinova AB (publ) (“Alzinova” or the “Company”) issued in connection with the issue of units with deviation from the shareholders’ pre-emption rights which the Company carried out in October 2020. The warrants are traded on Nasdaq First North Growth Market. Two (2) warrants entitle the holder to subscribe for one (1) new share in Alzinova at a subscription price of SEK 6.50. Upon full exercise of all warrants, Alzinova will receive approximately SEK 26.5 million before issue

News conference on Kojamo’s Financial Statements Release 2021 on 17 February 2022

Kojamo Plc Press Release, 3 February 2022 at 9:00 a.m. EETNews conference on Kojamo’s Financial Statements Release 2021 on 17 February 2022 Kojamo plc’s Financial Statements Release 2021 will be published on Thursday, 17 February 2022 at approximately 8:00 a.m. EET. Kojamo will publish Financial Statements and the Report of the Board of Directors as well as Corporate Governance Statement and Remuneration Report 2021 on the same day. News conference webcast Kojamo will hold a news conference for institutional investors, analysts and media on 17 February 2022 at 10:00 a.m. EET as a

Elisa publishes Sustainable Finance Framework

Elisa Corporation Investor News 3 FEBRUARY 2022 at 9:00 AMElisa has established a Sustainability Finance Framework to support the company's sustainability goals. Elisa can issue bonds and other financial instruments to finance or refinance sustainable investments and projects in accordance with the Framework. “Elisa's mission is a sustainable future through digitalisation. We are committed to the UN Sustainable Development Goals, and sustainability is part of our strategy. The company’s financing also reflects our sustainability goals. With this Sustainability Finance Framework and the

Wordzee passes five million downloads

Since its global launch in 2019, MAG's original word game has doubled its average revenue per daily active user.Stockholm, Sweden - 3 February, 2022 - MAG is pleased to announce today that the unique word game Wordzee has passed five million downloads. In Wordzee, players challenge each other to form words from letter tiles that are placed on a special game board. The player who fills the entire board takes home "Wordzee" and extra bonus points. Wordzee interweaves the gameplay of the classic dice game Yatzy with clever word game mechanics. The game was developed by MAG's studio in

Nexam Chemical is investing in a new production line - Strengthens the relationship with the customer and increases profitability

Nasdaq First North-listed Nexam Chemical, which helps plastics manufacturers around the world to improve their products - both in terms of durability and function - and thus competitiveness, is investing SEK 20 million in a new production line. The investment at the company's facility in Lomma, Skåne, will increase production capacity and improve profitability in the long run. In addition, the ability to meet customers' needs for the development of advanced products is strengthened.The new machine line, which will be an integral part of the existing production system, is planned to be

Share purchase agreement (SPA) signed between SBB and the municipal company Kalmar Kommunbolag AB for the acquisition of KIFAB i Kalmar AB and HB Telemarken for SEK 2,673m

Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) acquires 24 properties from Kalmar Kommunbolag AB. The property portfolio consists of a total lettable area of approximately 136,000 sq.m. and rental income in the 2022 level amounts to approximately SEK 158m. “SBB is the Nordic region's largest owner of social infrastructure in Europe and a long-term partner to many municipalities in the Nordic region when it comes to educational properties, both schools and universities. We look forward to supporting Kalmar's university ambitions and the strong focus on education. As an active player,

Hansa Biopharma year-end report 2021

· Commercial launch and market access efforts in Europe progressing as planned; new multiregional commercialization partnership with Medison Pharma  · First patients enrolled into the pivotal U.S. ConfIdeS study · Agreement established with AskBio to evaluate feasibility of imlifidase as pre-treatment ahead of gene therapy in Pompe disease · Platform strategy: Hansa to explore desensitization treatment in allogeneic hematopoietic stem cell transplantation · Year-end cash position of SEK 889 million; Hansa financed into 2023, as previously guidedLund, Sweden February 3, 2022

BioGaia’s probiotic reduces inflammation in patients with diverticulitis

A randomized, double-blind, placebo-controlled study with BioGaia’s probiotic strain Limosilactobacillus reuteri ATCC PTA 4659 was shown to reduce inflammation significantly more than placebo in patients with acute uncomplicated diverticulitis. Moreover, as hospitalization time was shorter in the probiotic group, the probiotic supplementation also had economic benefits.The study included 119 patients, 49 males and 70 females, diagnosed with acute uncomplicated diverticulitis. Mean age was 65 years. All patients were given fluids and bowel rest for 48 hours. Half of the group were

DDM Holding AG and DDM Debt AB to report fourth quarter and full year 2021

DDM Holding AG (First North Growth Market: DDM) and its subsidiary DDM Debt AB (Nasdaq Stockholm: DDM Debt 2026) will publish their Q4 and full year 2021 reports on Thursday 17 February 2022 at 08:00 CET. Mr. Florian Nowotny, CEO, and Mr. Fredrik Olsson, CFO, will host a conference call the same day, beginning at 10:00 CET, to present and comment on the DDM Group’s financial results. The conference will be held in English and can be followed live on www.ddm-group.ch  or by telephone with dial-in numbers: Sweden: +46 8 566 427 07

DDM Holding AG and DDM Debt AB to report fourth quarter and full year 2021

DDM Holding AG (First North Growth Market: DDM) and its subsidiary DDM Debt AB (Nasdaq Stockholm: DDM Debt 2026) will publish their Q4 and full year 2021 reports on Thursday 17 February 2022 at 08:00 CET. Mr. Florian Nowotny, CEO, and Mr. Fredrik Olsson, CFO, will host a conference call the same day, beginning at 10:00 CET, to present and comment on the DDM Group’s financial results. The conference will be held in English and can be followed live on www.ddm-group.ch  or by telephone with dial-in numbers: Sweden: +46 8 566 427 07

There are no items matching the current filter
There are no more items matching the current filter
Back to top